CD70 Targeting Therapies Clinical Trials Insight 2025: 20+ CD70 Targeting Therapies In Clinical Trials
31. Januar 2025 05:00 ET
|
Research and Markets
Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "CD70 Targeting Therapies Clinical Trials & Market Opportunity Insight 2025" report has been added to ResearchAndMarkets.com's offering. CD70...
CD47 Inhibitor Drug Clinical Trials Market Opportunity Outlook 2028, Competitive Analysis of Adagene, ALX, ImmuneOncia, ImmuneOnco, Light Chain Bioscience, Phanes, and Virtuoso,
29. Januar 2025 06:14 ET
|
Research and Markets
Dublin, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The "Global CD47 Inhibitor Drug Clinical Trials Insight & Market Opportunity Outlook 2028" report has been added to ResearchAndMarkets.com's offering. ...
$19.3 Bn Medical Device CRO Market Industry Trends and Global Forecasts, 2035: A Rapidly Changing Landscape Leading to a Surge in Demand for Novel Medical Devices Across Multiple Therapeutic Areas
29. Januar 2025 04:04 ET
|
Research and Markets
Dublin, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The "Medical Device CRO Market Industry Trends and Global Forecasts to 2035" report has been added to ResearchAndMarkets.com's offering. The global...
CD137 Antibodies Market Research 2024-2027: Increasing Investment in the Cancer Therapeutics Domain, Involvement of Prominent Companies Driving the CD137 Market
28. Januar 2025 11:13 ET
|
Research and Markets
Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "CD137 Antibodies Clinical Trials & Market Opportunity Insight" report has been added to ResearchAndMarkets.com's offering. The market potential...
Delta-like Ligand 3 (DLL3) Targeted Therapies Market Research 2025: 1 Drug, Imdelltra (Tarlatamab) Available / 10 Drugs by Company, Indication and Phase / Approved Drug Dosage, Sales & Pricing Insight
23. Januar 2025 07:51 ET
|
Research and Markets
Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "DLL3 Targeted Therapies Market, Approved Drugs, Dosage, Pricing & Clinical Trials Insight 2025" report has been added to ResearchAndMarkets.com's...
In Vivo CRO Market Projected to Reach USD 7.96 Billion by 2030 with Substantial Growth Across Regions and Segments
14. Januar 2025 10:49 ET
|
Research and Markets
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "In Vivo CRO Market Size, Share & Trends Analysis Report By Model Type, By Modality, By Indication, By GLP Type, By Region, And Segment Forecasts,...
Preclinical Contract Research Organizations (CRO) Business Report 2024: Global Market to Reach $11.3 Billion by 2030, Complex Drug Development Spurs Need for Specialized Preclinical Testing
10. Januar 2025 11:06 ET
|
Research and Markets
Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Preclinical Contract Research Organizations - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...
Oncology Based in-Vivo CRO Business Research Report 2024: Global Market to Reach $2.5 Billion by 2030 - Expansion in Drug Discovery, Translational Research, and Toxicology Fuels Growth
09. Januar 2025 04:01 ET
|
Research and Markets
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Oncology Based in-Vivo CRO - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Relapsed Multiple Myeloma Clinical Trials Review 2024: Clinical Trials by Region, Country, Trial Status, Trial Phase, Sponsor Type and End Point Status
27. Dezember 2024 04:34 ET
|
Research and Markets
Dublin, Dec. 27, 2024 (GLOBE NEWSWIRE) -- The "Relapsed Multiple Myeloma - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical...
Refractory Multiple Myeloma Global Clinical Trials Review 2024 - Top Level Data on Clinical Trials by Region, Country, Trial Status, Trial Phase, Sponsor Type and End Point Status
27. Dezember 2024 04:33 ET
|
Research and Markets
Dublin, Dec. 27, 2024 (GLOBE NEWSWIRE) -- The "Refractory Multiple Myeloma - Global Clinical Trials Review, 2024" has been added to ResearchAndMarkets.com's offering.The clinical trial report...